Compare Enveric Biosciences Inc (ENVB) vs Jones Lang LaSalle Inc (JLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Jones Lang LaSalle Inc — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while Jones Lang LaSalle Inc trades at $331.95 (market cap $15.21B). The key difference: Jones Lang LaSalle Inc is far larger — about 2859× Enveric Biosciences Inc's market cap, and Jones Lang LaSalle Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | JLL | |
|---|---|---|
Market Cap | $5.32M | $15.21B |
Sector | Health | Real Estate |
52-Week High | $17.40 | $358.66 |
52-Week Low | $1.28 | $250.46 |
Enterprise Value | $408.82K | $18.75B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JLL (Jones Lang LaSalle) stock trades at $330.31, up 5.06% on the day, showing strong momentum. The technical picture is bullish, with the price above key resistance levels. Fundamentally, the company has delivered three consecutive earnings beats, with revenue growing to $26.12B in 2025 and net income margin improving to 3.03%. Recent news highlights significant capital markets activity, including a $332M Chicago tower refinancing and a study suggesting AI will drive workforce growth, not cuts.
The outlook is positive, supported by analyst consensus for a 25% upside to a $405.50 price target and a 'Buy' rating from 55% of covering analysts. Key opportunities include continued execution in capital markets and property services, while risks involve exposure to commercial real estate cycles and potential macroeconomic headwinds affecting transaction volumes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →
